Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puneet Dewan

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Plos One|March 29, 2020
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysisNimalan Arinaminpathy, Gabriela B Gomez, Kuldeep S Sachdeva, et al.
Plos One|March 8, 2013
What are the reasons for poor uptake of HIV testing among patients with TB in an Eastern India District?Bipra Bishnu, Sudipto Bhaduri, Ajay M V Kumar, et al.
BMC Infectious Diseases|June 21, 2019
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales dataNimalan Arinaminpathy, Deepak Batra, Nilesh Maheshwari, et al.
Plos One|June 6, 2019
What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in IndiaSarang Deo, Pankaj Jindal, Devesh Gupta, et al.
Plos One|June 1, 2016
HIV Testing among Patients with Presumptive Tuberculosis: How Do We Implement in a Routine Programmatic Setting? Results of a Large Operational Research from IndiaAjay Mv Kumar, Devesh Gupta, Ashok Kumar, et al.
Plos One|March 4, 2014
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in IndiaNeeraj Raizada, K S Sachdeva, Achuthan Sreenivas, et al.
BMJ Global Health|January 8, 2020
Initiative for Promoting Affordable and Quality Tuberculosis Tests (IPAQT): a market-shaping intervention in IndiaHarkesh Dabas, Sarang Deo, Manisha Sabharwal, et al.
Plos One|October 25, 2011
How do patients who fail first-line TB treatment but who are not placed on an MDR-TB regimen fare in South India?Sharath Burugina Nagaraja, Srinath Satyanarayana, Sarabjit Singh Chadha, et al.
Plos One|September 21, 2011
Will adoption of the 2010 WHO ART guidelines for HIV-infected TB patients increase the demand for ART services in India?Ajay M V Kumar, Devesh Gupta, B B Rewari, et al.
Plos One|August 17, 2021
Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assaysChristine M Bachman, Benjamin D Grant, Caitlin E Anderson, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Plos One|March 29, 2020
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysisNimalan Arinaminpathy, Gabriela B Gomez, Kuldeep S Sachdeva, et al.
Plos One|March 8, 2013
What are the reasons for poor uptake of HIV testing among patients with TB in an Eastern India District?Bipra Bishnu, Sudipto Bhaduri, Ajay M V Kumar, et al.
BMC Infectious Diseases|June 21, 2019
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales dataNimalan Arinaminpathy, Deepak Batra, Nilesh Maheshwari, et al.
Plos One|June 6, 2019
What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in IndiaSarang Deo, Pankaj Jindal, Devesh Gupta, et al.
Plos One|June 1, 2016
HIV Testing among Patients with Presumptive Tuberculosis: How Do We Implement in a Routine Programmatic Setting? Results of a Large Operational Research from IndiaAjay Mv Kumar, Devesh Gupta, Ashok Kumar, et al.
Plos One|March 4, 2014
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in IndiaNeeraj Raizada, K S Sachdeva, Achuthan Sreenivas, et al.
BMJ Global Health|January 8, 2020
Initiative for Promoting Affordable and Quality Tuberculosis Tests (IPAQT): a market-shaping intervention in IndiaHarkesh Dabas, Sarang Deo, Manisha Sabharwal, et al.
Plos One|October 25, 2011
How do patients who fail first-line TB treatment but who are not placed on an MDR-TB regimen fare in South India?Sharath Burugina Nagaraja, Srinath Satyanarayana, Sarabjit Singh Chadha, et al.
Plos One|September 21, 2011
Will adoption of the 2010 WHO ART guidelines for HIV-infected TB patients increase the demand for ART services in India?Ajay M V Kumar, Devesh Gupta, B B Rewari, et al.
Plos One|August 17, 2021
Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assaysChristine M Bachman, Benjamin D Grant, Caitlin E Anderson, et al.
Pageof 4